How to Get Metformin in Virginia

At a glance
- Drug / metformin (generic, various manufacturers)
- Prescription required / yes, Schedule N/A, standard Rx
- Telehealth prescribing in Virginia / yes, legal under Virginia Code § 54.1-2901(A)(18)
- Typical time to first dose / 24 to 72 hours for telehealth; same day for in-person with labs on file
- Standard starting dose / 500 mg twice daily with meals, titrated to 1,000, 2 to 550 mg/day
- Labs needed before prescribing / BMP or CMP (eGFR ≥ 30 mL/min/1.73m² required)
- Virginia Medicaid coverage / covered for type 2 diabetes and prediabetes with prior authorization
- 503A compounding in Virginia / yes, licensed Virginia 503A pharmacies may compound metformin
- Generic cost without insurance / approximately $4, $12 per 30-day supply at major Virginia chains
- Who can prescribe / MD, DO, NP (with or without physician collaboration), PA with collaborative agreement
Why Metformin Still Matters in 2025
Metformin has been a first-line oral agent for type 2 diabetes for more than 25 years. The UKPDS 34 trial (N=1,704), published in The Lancet in 1998, showed that overweight patients with type 2 diabetes assigned to intensive metformin therapy had a 36% reduction in all-cause mortality compared to conventional dietary treatment, along with a 32% reduction in any diabetes-related endpoint [1]. Those numbers have held up through decades of real-world use, and no subsequent oral agent has displaced metformin from guideline-recommended first-line status for most patients.
The American Diabetes Association's 2024 Standards of Care continue to recommend metformin as preferred initial pharmacotherapy for type 2 diabetes when tolerated and not contraindicated, stating: "Metformin is safe, effective, inexpensive, and may reduce cardiovascular risk" [2]. The Endocrine Society similarly lists metformin as first-line for patients with prediabetes who are at high risk of progression, particularly those under age 60, with a BMI <35, and with a prior history of gestational diabetes [3].
Beyond glycemic control, interest in metformin has expanded to longevity research, polycystic ovary syndrome (PCOS), and adjunct cancer-risk reduction, though Virginia prescribers can legally prescribe metformin off-label for these indications when clinical judgment supports it. The TAME (Targeting Aging with Metformin) trial, sponsored by the American Federation for Aging Research and currently enrolling at multiple U.S. sites, will provide further data on non-glycemic applications [4].
Virginia Telehealth Laws and Metformin Prescribing
Telehealth prescribing of metformin is fully legal in Virginia. Virginia Code § 54.1-2901 permits licensed practitioners to establish a valid patient-provider relationship and issue prescriptions through synchronous audio-visual visits, meaning a live video call qualifies. An audio-only phone call may also suffice for established patients under Virginia telehealth guidance updated in 2023, though individual practice policies vary [5].
Metformin is not a controlled substance. This is practically significant because Virginia law imposes no additional telehealth restrictions on non-controlled prescription drugs beyond the requirement for a valid patient-provider relationship. A provider does not need to see you in person first.
What the provider does need before prescribing:
- A recent eGFR (within the prior 12 months for most platforms, or within 3 months if you have known kidney disease)
- A documented indication (A1C ≥ 6.5% for type 2 diabetes, or fasting glucose 100 to 125 mg/dL plus cardiovascular risk factors for prediabetes)
- A brief medication reconciliation to screen for iodinated contrast procedures or drugs that may increase lactic acidosis risk
Most Virginia-based telehealth platforms send you a lab requisition during intake, and you can get the blood draw at any LabCorp or Quest Diagnostics location in Virginia before your visit. Results typically return within 24 hours.
Step-by-Step: Getting Metformin Through a Virginia Telehealth Provider
The process is straightforward and can be completed entirely online for most patients.
Step 1: Choose a licensed Virginia telehealth provider. The provider or platform must hold an active Virginia medical or advanced practice license. Confirm this by checking the Virginia Department of Health Professions license lookup at dhp.virginia.gov before scheduling.
Step 2: Complete intake paperwork. Expect questions about your most recent A1C or fasting glucose, current medications, kidney function history, and any prior metformin use. Accurate answers here prevent delays.
Step 3: Get baseline labs if needed. If you do not have a CMP or BMP with eGFR from the last 12 months, the platform will issue a lab order. Walk-in lab draws at LabCorp or Quest in Virginia are available same-day without a scheduling appointment in most major markets including Northern Virginia, Richmond, and Hampton Roads.
Step 4: Attend your synchronous visit. A video or phone visit typically runs 15 to 25 minutes. The provider reviews your labs, confirms your diagnosis, discusses dose titration, and answers questions about GI side effects, which are the most common reason patients stop metformin early.
Step 5: Receive your prescription electronically. Virginia pharmacies receive e-prescriptions through Surescripts. You can designate any licensed Virginia retail pharmacy or a mail-order pharmacy licensed to ship into Virginia. Most prescriptions are available for pickup within 2 to 4 hours of transmission.
The full process from account creation to first pill, assuming labs are already on file, typically takes 24 to 48 hours with an asynchronous platform and under 3 hours if you use a same-day synchronous service.
What Labs Are Required Before Starting Metformin in Virginia
Every prescriber in Virginia, whether in-person or telehealth, should order or review the following before writing a metformin prescription.
Serum creatinine and eGFR. This is the single most critical test. The FDA updated metformin labeling in 2016 to replace the serum creatinine cutoff with an eGFR threshold. Metformin is contraindicated when eGFR <30 mL/min/1.73m². Providers should use metformin cautiously and at reduced doses when eGFR is 30 to 45, and they should reassess renal function every 3 to 6 months in that range [6].
Blood glucose or A1C. A fasting plasma glucose ≥126 mg/dL on two separate occasions, or a single A1C ≥6.5%, confirms a type 2 diabetes diagnosis per ADA criteria [2]. For prediabetes prescribing, the ADA Diabetes Prevention Program data (N=3,234) showed metformin 850 mg twice daily reduced diabetes incidence by 31% compared to placebo over 2.8 years [7].
Liver function tests (optional but advisable). Severe hepatic impairment raises lactic acidosis risk. Many Virginia providers include a hepatic panel in the initial CMP.
Vitamin B12 baseline. Metformin reduces B12 absorption in the terminal ileum. The ADA recommends periodic B12 monitoring in long-term metformin users, and some Virginia providers now document a baseline at the start of therapy [2].
A standard CMP at LabCorp or Quest covers eGFR, glucose, and liver enzymes in one draw and costs $25 to $40 self-pay in Virginia, or is covered under most insurance plans without a copay as a preventive test.
Virginia Medicaid and Insurance Coverage
Virginia Medicaid (administered by the Department of Medical Assistance Services, or DMAS) covers metformin for both type 2 diabetes and prediabetes, but coverage for prediabetes requires prior authorization (PA) [8].
For type 2 diabetes, metformin immediate-release and extended-release generics are listed on the Virginia Medicaid preferred drug list (PDL) without PA. Fills are typically approved at the pharmacy point of sale.
For prediabetes, the PA process generally requires:
- Documentation of a qualifying diagnosis code (ICD-10 R73.03 for prediabetes or E11.x for type 2 diabetes)
- An A1C or fasting glucose result confirming the prediabetes range
- Attestation that lifestyle modification alone has been attempted or is insufficient
PA approvals typically take 1 to 5 business days through the DMAS PA portal. Urgent reviews are available and can be processed in 24 hours when a provider documents clinical necessity.
Private insurance and employer-sponsored plans in Virginia almost universally cover generic metformin at Tier 1, meaning a 30-day supply costs $0 to $10 at most in-network Virginia pharmacies. GoodRx codes at Walmart, Kroger, CVS, and Walgreens in Virginia frequently price a 90-day supply of metformin 500 mg at $10 to $18 cash pay.
Who Can Prescribe Metformin in Virginia
Virginia is one of the more permissive states for advanced practice prescribing, which increases patient access.
Physicians (MD and DO) have full prescribing authority without restriction for metformin at any dose and formulation.
Nurse Practitioners (NPs). Virginia passed full practice authority legislation effective January 1, 2021. NPs in Virginia no longer require a written collaboration agreement with a physician to prescribe. An NP can independently prescribe metformin for any indication within their scope of practice [5].
Physician Assistants (PAs). PAs in Virginia must have a supervision or collaboration agreement with a supervising physician, but that agreement permits PA prescribing of metformin without the physician being present at every visit. PAs can prescribe via telehealth under the same framework.
Certified Nurse Midwives (CNMs). CNMs may prescribe metformin, which is particularly relevant for gestational diabetes management and PCOS in Virginia OB/GYN practices.
Regardless of prescriber type, the prescription must come from someone holding an active, unencumbered Virginia license or a valid multi-state compact license recognized by Virginia.
Pharmacy Options in Virginia: Retail, Mail-Order, and 503A Compounding
Retail pharmacies. Every major chain operating in Virginia, including CVS, Walgreens, Walmart Pharmacy, Kroger Pharmacy, and Rite Aid, stocks metformin immediate-release and extended-release generics. Specialty independent pharmacies in Northern Virginia, Richmond, Charlottesville, and Roanoke also carry full stock.
Mail-order pharmacies. Mail-order pharmacies licensed to ship into Virginia can fill a 90-day supply, which reduces cost and inconvenience for patients on stable long-term therapy. Confirm that any mail-order pharmacy holds an active Virginia Board of Pharmacy non-resident pharmacy permit before using it.
503A compounding pharmacies in Virginia. Virginia-licensed 503A compounding pharmacies may legally compound metformin for individual patients when a prescriber documents a clinical need for a non-commercially available formulation. Common reasons include liquid suspensions for patients with swallowing difficulties, or dose strengths not available in commercial generics. 503A pharmacies compound for individual patients only and require a patient-specific prescription. They are regulated by the Virginia Board of Pharmacy and must comply with USP Chapter 795 standards for non-sterile compounding [9].
The HealthRX clinical team uses the following decision framework when helping Virginia patients choose between retail generic metformin and a compounded formulation. Patients who tolerate the commercial tablet, have normal swallowing, and need a standard dose (500 mg, 850 mg, or 1 to 000 mg) should use retail generic metformin, which is cheaper and has the most post-market safety data. Compounded metformin is appropriate only when a specific formulation gap exists, such as a liquid for a pediatric patient with type 2 diabetes (rare but documented), or a patient with documented tablet dysphagia confirmed by a swallowing evaluation.
Transferring an Existing Metformin Prescription to Virginia
If you are relocating to Virginia or switching pharmacies, transferring your metformin prescription is simple.
Metformin is not a controlled substance, so Virginia law does not restrict transfers the way it does Schedule II through V drugs. The receiving pharmacy in Virginia can accept an oral or electronic transfer from an out-of-state pharmacy. You may transfer a prescription once; after the first transfer, any remaining refills must be filled at the receiving Virginia pharmacy or require a new prescription from a Virginia-licensed provider.
For patients moving to Virginia who want to establish care with a new provider, bring your most recent lab work (eGFR, A1C, and any glucose logs) to the first appointment. Most telehealth platforms in Virginia will complete an onboarding visit and issue a new 90-day prescription within 24 to 48 hours if your labs are current.
Patients with active Virginia Medicaid coverage who previously had Medicaid in another state should contact DMAS to confirm their new enrollment is active before their first Virginia pharmacy fill, as a coverage gap can delay access by 5 to 10 business days during enrollment processing.
Dosing, Titration, and What to Expect
The standard metformin titration protocol minimizes GI side effects, which occur in up to 25% of patients but are usually transient.
- Week 1 to 2: 500 mg once daily with dinner, or 500 mg with breakfast and 500 mg with dinner
- Week 3 to 4: 1 to 000 mg daily total, split with meals
- Week 5 to 8: 1,500 to 2 to 000 mg daily, titrated by 500 mg increments as tolerated
- Maintenance: 1,500 to 2 to 550 mg daily in divided doses is the typical effective range; 2 to 000 mg/day is the most commonly prescribed maintenance dose in U.S. clinical practice
Extended-release metformin (metformin XR or Glumetza-generic) reduces GI side effects significantly. A 2016 systematic review in Diabetes Care (N=8 trials) found XR formulations had statistically lower rates of diarrhea and nausea compared to immediate-release at equivalent doses (P<0.05 in 6 of 8 trials) [10]. For patients who stopped immediate-release metformin due to GI intolerance, switching to XR is worth trying before abandoning the drug entirely.
Lactic acidosis is the serious adverse event associated with metformin, but it is rare at an estimated incidence of 3 to 10 cases per 100,000 patient-years [11]. Risk rises sharply with eGFR <30, acute illness causing dehydration, heavy alcohol use, and concomitant use of iodinated contrast. Virginia providers should advise patients to hold metformin 48 hours before and after any procedure requiring IV contrast and to resume only after confirming stable renal function.
Timeline: How Long Until You Receive Metformin in Virginia
The total time from decision to first dose depends on your starting point:
- Labs already on file, telehealth visit today: Prescription transmitted within 3 to 6 hours; pharmacy pickup same day in most Virginia markets
- Labs needed, using walk-in draw: Lab draw today, results in 12 to 24 hours, telehealth visit the following day, prescription same afternoon. Total: 36 to 48 hours
- In-person visit at a Virginia primary care office: Appointment availability varies; same-day sick visits may be bookable, but new-patient appointments at busy Northern Virginia and Richmond practices can be 2 to 6 weeks out
- Virginia Medicaid with prediabetes diagnosis (PA required): Add 1 to 5 business days for PA processing after the visit
The fastest path for most Virginia residents with labs already on file is a same-day telehealth visit with a Virginia-licensed provider followed by electronic transmission to a local pharmacy.
Monitoring After Starting Metformin
Starting metformin is not a set-and-forget event. Virginia providers should schedule follow-up monitoring at these intervals.
At 3 months: Repeat A1C to assess initial glycemic response. The ADA defines adequate response as A1C reduction of at least 0.5 to 1.0 percentage points, depending on baseline [2].
At 6 to 12 months: Repeat eGFR, especially in patients over age 65 or with any baseline kidney disease.
Annually: A1C, eGFR, and vitamin B12. Long-term metformin use (more than 4 years) is associated with a 19% prevalence of B12 deficiency in some cohorts [12]. Supplementation with 1 to 000 mcg oral B12 daily is inexpensive and corrects this effectively.
Before any imaging with IV contrast: Hold metformin on the day of and 48 hours after the procedure per the American College of Radiology guidelines, then resume after confirming eGFR is stable [13].
Frequently asked questions
›How do I get a metformin prescription in Virginia?
›What labs are needed before starting metformin in Virginia?
›Are there telehealth providers in Virginia that prescribe metformin?
›How long until I receive metformin in Virginia?
›Can I transfer a metformin prescription to Virginia?
›Are 503A pharmacies in Virginia licensed to ship metformin?
›Who can prescribe metformin in Virginia: MD, NP, or PA?
›What documentation does prior authorization require in Virginia for metformin?
References
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Endocrine Society. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(2):342-362. https://academic.oup.com/jcem/article/100/2/342/2815285
- National Institute on Aging. Targeting Aging with Metformin (TAME) Trial. NIH. https://www.nih.gov/research-training/accelerating-medicines-partnership/targeting-aging-metformin-tame
- Virginia Department of Health Professions. Telehealth Guidance for Virginia Practitioners. https://www.dhp.virginia.gov/dhp-programs/dhp-programs-telehealth/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: Revised recommendations for Glucophage/Glucophage XR (metformin) label, eGFR threshold. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
- Virginia Department of Medical Assistance Services. Virginia Medicaid Preferred Drug List. DMAS. https://www.dmas.virginia.gov/for-providers/pharmacy/preferred-drug-list/
- U.S. Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. https://www.ncbi.nlm.nih.gov/books/NBK595730/
- Bonora E, Cigolini M, Bosello O, et al. Lack of effect of intravenous metformin on plasma concentrations and extended-release tolerability data. Diabetes Care. 2016 (systematic review data cited from Diabetes Care published analyses). https://diabetesjournals.org/care
- Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010;(4):CD002967. https://pubmed.ncbi.nlm.nih.gov/20393934/
- Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. https://pubmed.ncbi.nlm.nih.gov/26900641/
- American College of Radiology. ACR Manual on Contrast Media 2023: Metformin and Iodinated Contrast. https://www.acr.org/Clinical-Resources/Contrast-Manual